Mylan trying again to quell price outrage
Critics fault drug maker over plans for a generic version of its own EpiPen
‘‘Today’s announcement is just one more convoluted mechanism to avoid plain talk, admit to price gouging and just cut the price of EpiPen.’’
BY ANDREW POLLACK Katie Thomas contributed reporting.
In its latest move to quell outrage over its price increases, the maker of the EpiPen has resorted to an unusual tactic — introducing a generic version of its own product.
The company, Mylan, said on Monday that the generic EpiPen would be identical...
Read latest International New York Times Asia online.